ReaDySpeech for people with dysarthria after stroke
| ISRCTN | ISRCTN84996500 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN84996500 |
| Protocol serial number | 18964 |
| Sponsor | University of Manchester |
| Funder | National Institute for Health Research |
- Submission date
- 20/05/2015
- Registration date
- 21/05/2015
- Last edited
- 24/01/2019
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Circulatory System
Plain English summary of protocol
Background and study aims
Dysarthria, or slurred speech, is caused by muscle weakness and is common after a stroke. It happens when areas of the brain or nervous system that control the muscles used for speech are damaged. Dysarthria can lead to people feeling isolated, unconfident and uncomfortable in social situations. Speech therapy can offer support to people with dysarthria and help to reduce its symptoms, but this treatment is not always provided within the NHS. The aim of this study is to test a new technology called ReaDySpeech, a specially designed computer programme which aims to provide patients with greater access to personalised speech rehabilitation. ReaDySpeech technology will be trialled in this study with both clinicians and patients to see what they think of it. If clinicians and patients find the technology acceptable, a larger study will be designed from its results so that it can be tested with more people.
Who can participate?
Adults with dysarthria following a stroke.
What does the study involve?
All participants are given access to the ReaDySpeech computer programme. Users are asked to provide feedback on ReaDySpeech.
What are the possible benefits and risks of participating?
Not provided at time of registration.
Where is the study run from?
University of Manchester (UK)
When is the study starting and how long is it expected to run for?
September 2015 to November 2016
Who is funding the study?
National Institute for Health Research (UK)
Who is the main contact?
Mrs C Mitchell
Contact information
Scientific
University of Manchester
Oxford Road
Manchester
M13 9PL
United Kingdom
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised interventional treatment study |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | ReaDySpeech for people with dysarthria after stroke: a feasibility study |
| Study objectives | This study will test the feasibility of a new speech rehabilitation technology, ReaDySpeech, developed for patients with dysarthria. This study will assess its acceptability with clinicians and patients, and the results will be used in the design of a larger study. |
| Ethics approval(s) | Ref: 15/NW/0371. |
| Health condition(s) or problem(s) studied | Stroke rehabilitation for dysarthria |
| Intervention | Participants will be given access to ReaDySpeech, a computer based programme designed to deliver speech therapy exercises to patients. |
| Intervention type | Other |
| Primary outcome measure(s) |
Activity measure. |
| Key secondary outcome measure(s) |
Not available at time of registration. |
| Completion date | 01/11/2016 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | All |
| Target sample size at registration | 36 |
| Key inclusion criteria | 1. Participants will be selected by the clinician, within the inclusion criteria of more than 1 week post stroke 2. No upper limit to time post stroke 3. Participants will present with dysarthria, willing and able to undertake communication therapy (in clinicians' opinion) 4. Sufficient ability in English to participate in therapy without a translator 5. Medically stable 6. Able to give informed consent to participate |
| Key exclusion criteria | 1. Dysarthria for reason other than stroke 2. Not fluent in the English language (this may make using ReaDySpeech difficult) 3. Coexisting communication, cognitive, hearing or visual problems, significant enough to make using ReaDySpeech difficult 4. Coexisting progressive neurological condition |
| Date of first enrolment | 01/09/2015 |
| Date of final enrolment | 01/11/2016 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Manchester
M13 9PL
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 01/08/2018 | 24/01/2019 | Yes | No |
| Protocol article | protocol | 20/07/2017 | Yes | No | |
| HRA research summary | 28/06/2023 | No | No | ||
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
24/01/2019: Publication reference added
24/07/2017: Publication reference added.
